or Try an Advanced Search...

    Technical Analysis for CNSP - CNS Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.21 0.00% 0.00
    CNSP closed up 5.47 percent on Tuesday, April 23, 2024, on 55 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 13
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical CNSP trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 5.47%
    Wide Bands Range Expansion 5.47%
    Down 3 Days in a Row Weakness 5.47%
    Down 4 Days in a Row Weakness 5.47%
    Down 5 Days in a Row Weakness 5.47%
    Oversold Stochastic Weakness 5.47%
    New 52 Week Closing Low Bearish 3.96%
    Wide Bands Range Expansion 3.96%
    Older End-of-Day Signals for CNSP ...

       Recent Intraday Alerts

    Alert Time
    Down 3% 1 minute ago
    Down 2 % 1 minute ago
    Down 1% 1 minute ago
    10 DMA Resistance 16 minutes ago
    Rose Above Previous Day's High 24 minutes ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CNSP Chart by TradingView
    Basic chart:

    Profile

    CNS Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. Its lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma. The company was founded in 2017 and is based in Houston, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Oncology Blastoma Glioblastoma Stage Pharmaceutical Brain Tumor Evofosfamide Central Nervous System Tumors

    Is CNSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 23 CNS Pharmaceuticals to Present at the LSX World Congress 2024
    Apr 22 CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
    Apr 1 CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
    Apr 1 CNS Pharmaceuticals to Present at Two Investor Conferences in April
    Feb 9 Top 5 Health Care Stocks That Are Preparing To Pump In February
    Jan 30 CNS Pharmaceuticals prices $4M public offering
    Jan 30 CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
    Jan 18 Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors
    Jan 17 CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
    Dec 18 CNS Pharmaceuticals Announces Successful Interim Analysis of Efficacy and Safety Data in Potentially Pivotal Study of Berubicin
    See more CNSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.98
    52 Week Low 0.19
    Average Volume 258,091
    200-Day Moving Average 1.25
    50-Day Moving Average 0.31
    20-Day Moving Average 0.26
    10-Day Moving Average 0.22
    Average True Range 0.03
    RSI (14) 31.03
    ADX 26.66
    +DI 13.83
    -DI 24.69
    Chandelier Exit (Long, 3 ATRs) 0.29
    Chandelier Exit (Short, 3 ATRs) 0.29
    Upper Bollinger Bands 0.38
    Lower Bollinger Band 0.14
    Percent B (%b) 0.28
    BandWidth 91.31
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram -0.0014
    Fundamentals Value
    Market Cap 1.77 Million
    Num Shares 8.43 Million
    EPS -7.60
    Price-to-Earnings (P/E) Ratio -0.03
    Price-to-Sales 0.00
    Price-to-Book 4.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.24
    Resistance 3 (R3) 0.24 0.23 0.24
    Resistance 2 (R2) 0.23 0.22 0.23 0.24
    Resistance 1 (R1) 0.22 0.21 0.22 0.22 0.23
    Pivot Point 0.21 0.21 0.21 0.21 0.21
    Support 1 (S1) 0.20 0.20 0.20 0.20 0.19
    Support 2 (S2) 0.18 0.19 0.18 0.18
    Support 3 (S3) 0.17 0.18 0.18
    Support 4 (S4) 0.18